DSpace at RU >

Browsing by Author Asperen, C.J. van

Full Text	Issue Date	Title	Author(s)
	2011	Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers	Im, K.M.; Kirchhoff, T.; Wang, X.; Green, T.; Chow, C.Y., et al
	2011	Exploring the link between MORF4L1 and risk of breast cancer.	Martrat, G.; Maxwell, C.M.; Tominaga, E.; Porta-de-la-Riva, M.; Bonifaci, N., et al
	2011	Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.	Cox, D.G.; Simard, J.; Sinnett, D.; Hamdi, Y.; Soucy, P., et al
	2011	Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2	Osorio, A.; Milne, R.L.; Alonso, R.; Pita, G.; Peterlongo, P., et al
	2011	Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers	Ramus, S.J.; Kartsonaki, C.; Gayther, S.A.; Pharoah, P.D.; Sinilnikova, O.M., et al
	2011	Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers	Antoniou, A.C.; Kartsonaki, C.; Sinilnikova, O.M.; Soucy, P.; McGuffog, L., et al
	2011	Body weight and risk of breast cancer in BRCA1/2 mutation carriers	Manders, P.; Pijpe, A.; Hooning, M.J.; Kluijt, I.; Vasen, H.F., et al
	2011	Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium	Broeks, A.; Schmidt, M.K.; Sherman, M.E.; Couch, F.J.; Hopper, J.L., et al
	2010	Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers.	Pijpe, A.; Manders, P.; Brohet, R.M.; Collee, J.M.; Verhoef, S., et al
	2010	TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.	Ruijs, M.W.; Verhoef, S.; Rookus, M.A.; Pruntel, R.; Hout, A.H. van der, et al
	2010	Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.	Antoniou, A.C.; Beesley, J.; McGuffog, L.; Sinilnikova, O.M.; Healey, S., et al
	2009	A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example	Mohammadi, L.; Vreeswijk, M.P.; Oldenburg, R.; Ouweland, A.M.W. van den; Oosterwijk-Wakka, J.C., et al
	2009	A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history.	Gomez Garcia, E.B.; Oosterwijk-Wakka, J.C.; Timmermans, M.; Asperen, C.J. van; Hogervorst, F.B.L., et al
	2007	The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study.	Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
	2007	Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.	Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
	2007	Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.	Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
	2007	Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.	Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
	2007	A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships.	Oostrom, I.I.H. van; Meijers-Heijboer, H.; Duivenvoorden, H.J.; Brocker-Vriends, A.H.; Asperen, C.J. van, et al
	2006	Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.	Oldenburg, R.A.; Kroeze-Jansema, K.; Meijers-Heijboer, H.; Asperen, C.J. van; Hoogerbrugge-van der Linden, N., et al
	2005	Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.	Asperen, C.J. van; Brohet, R.M.; Meijers-Heijboer, E.J.; Hoogerbrugge-van der Linden, N.; Verhoef, S., et al
	1997	A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families	Peelen, T.; Vliet, M. van; Petrij-Bosch, A.; Mieremet, R.; Szabo, C., et al